agilon health, inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
agilon health, inc. (AGL) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $12.32 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-25
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $12.32M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $11.93M.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $9.12M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $12.32M 10-K · filed 2026-02-25 |
| 2024-12-31 | $11.93M 10-K · filed 2025-02-25 |
| 2023-12-31 | $9.12M 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |